NEW YORK---The first major study of
the genome of the SARS virus shows that it has not mutated significantly in its
spread to different countries.
.
The findings were encouraging because
if the virus remains stable, chances are increased that a vaccine might be
developed, the authors and other experts said Thursday. That effort is expected
to take years.
.
But the experts said that the
findings also meant that SARS, unlike some other new and emerging diseases, had
not weakened as it passed through successive generations. Some experts had
expressed hope that the virus would cause less severe illness as it spread.
.
Also, in a report on the outbreak in
Singapore, the U.S. Centers for Disease Control and Prevention said that five
individuals had acted as "superspreaders" in passing the virus to 144 other
people, while 81 percent of infected people did not transmit to anyone else.
.
The U.S. health agency defined
superspreaders as individuals who transmitted SARS to 10 or more people. Doctors
have described superspreaders in other infections like tuberculosis, rubella and
Ebola.
.
The director of the agency, Dr. Julie
Gerberding, said her agency was making available to state health departments the
biological material needed to perform a diagnostic blood test. The test detects
the antibodies that the immune system forms as it fights off infections; the
immune system produces a specific antibody against each microbe.
.
Researchers at the Centers for
Disease Control have developed a test like the Elisa, which is used to screen
for the AIDS virus and other infectious agents. The SARS test is expected to
have limited use because it cannot detect antibodies until three weeks after the
onset of illness. A positive result would strongly indicate that an individual
had been infected with the SARS virus, but a negative test would not necessarily
rule out such infection, Gerberding said.
.
"Probably the most important lesson
that we learned from the Singapore experience" is the need to "remain vigilant,"
she said. "If we were unfortunate to have someone with unrecognized SARS," who
could infect many others, "we could have a cascade of transmission."
.
The genome study, by Dr. Edison Liu
and his team in Singapore, involved comparing the complete genomes of SARS virus
from nine cases there with virus samples isolated in Canada, China, Hong Kong
and Vietnam. The study was published in The Lancet.
.
"This is the first major analysis of
this virus," said Dr. David Heymann, executive director of communicable diseases
at the World Health Organization. The Geneva-based agency has overall
responsibility for investigating the epidemic, which has affected 29 countries.
.
A number of laboratories have also
found that the SARS virus has not mutated significantly in the seven weeks since
it was detected, Heymann said.
.
Dr. Earl Brown, a virologist at the
University of Ottawa, said: "I hope that SARS will change, but I'm concerned.
This virus seems to be happy with the genes it's got." Brown, in a commentary on
the study in The Lancet, suggested that because the SARS virus had changed
relatively little in its first few months, it seemed unlikely to mutate into a
milder form.
.
In an interview, Brown said that if a
new virus was going to evolve into a more benign form, it normally did so in the
early months of an outbreak, a pattern followed by the Ebola virus, which causes
a deadly hemorrhagic fever.
.
"Ebola transmits like wildfire in
hospitals and among family members for two or three transmissions and then loses
the ability to infect people," he said. "It loses the ability to spread and keep
its virulence, and burns out on its own."
.
The World Health Organization has
said that a newly discovered member of the coronavirus family causes SARS. But
the agency and other scientists agree that more work needs to be done to be
certain.
.
The New York Times NEW YORK The first
major study of the genome of the SARS virus shows that it has not mutated
significantly in its spread to different countries.
.
The findings were encouraging because
if the virus remains stable, chances are increased that a vaccine might be
developed, the authors and other experts said Thursday. That effort is expected
to take years.
.
But the experts said that the
findings also meant that SARS, unlike some other new and emerging diseases, had
not weakened as it passed through successive generations. Some experts had
expressed hope that the virus would cause less severe illness as it spread.
.
Also, in a report on the outbreak in
Singapore, the U.S. Centers for Disease Control and Prevention said that five
individuals had acted as "superspreaders" in passing the virus to 144 other
people, while 81 percent of infected people did not transmit to anyone else.
.
The U.S. health agency defined
superspreaders as individuals who transmitted SARS to 10 or more people. Doctors
have described superspreaders in other infections like tuberculosis, rubella and
Ebola.
.
The director of the agency, Dr. Julie
Gerberding, said her agency was making available to state health departments the
biological material needed to perform a diagnostic blood test. The test detects
the antibodies that the immune system forms as it fights off infections; the
immune system produces a specific antibody against each microbe.
.
Researchers at the Centers for
Disease Control have developed a test like the Elisa, which is used to screen
for the AIDS virus and other infectious agents. The SARS test is expected to
have limited use because it cannot detect antibodies until three weeks after the
onset of illness. A positive result would strongly indicate that an individual
had been infected with the SARS virus, but a negative test would not necessarily
rule out such infection, Gerberding said.
.
"Probably the most important lesson
that we learned from the Singapore experience" is the need to "remain vigilant,"
she said. "If we were unfortunate to have someone with unrecognized SARS," who
could infect many others, "we could have a cascade of transmission."
.
The genome study, by Dr. Edison Liu
and his team in Singapore, involved comparing the complete genomes of SARS virus
from nine cases there with virus samples isolated in Canada, China, Hong Kong
and Vietnam. The study was published in The Lancet.
.
"This is the first major analysis of
this virus," said Dr. David Heymann, executive director of communicable diseases
at the World Health Organization. The Geneva-based agency has overall
responsibility for investigating the epidemic, which has affected 29 countries.
.
A number of laboratories have also
found that the SARS virus has not mutated significantly in the seven weeks since
it was detected, Heymann said.
.
Dr. Earl Brown, a virologist at the
University of Ottawa, said: "I hope that SARS will change, but I'm concerned.
This virus seems to be happy with the genes it's got." Brown, in a commentary on
the study in The Lancet, suggested that because the SARS virus had changed
relatively little in its first few months, it seemed unlikely to mutate into a
milder form.
.
In an interview, Brown said that if a
new virus was going to evolve into a more benign form, it normally did so in the
early months of an outbreak, a pattern followed by the Ebola virus, which causes
a deadly hemorrhagic fever.
.
"Ebola transmits like wildfire in
hospitals and among family members for two or three transmissions and then loses
the ability to infect people," he said. "It loses the ability to spread and keep
its virulence, and burns out on its own."
.
The World Health Organization has
said that a newly discovered member of the coronavirus family causes SARS. But
the agency and other scientists agree that more work needs to be done to be
certain.
.
The New York Times NEW YORK The first
major study of the genome of the SARS virus shows that it has not mutated
significantly in its spread to different countries.
.
The findings were encouraging because
if the virus remains stable, chances are increased that a vaccine might be
developed, the authors and other experts said Thursday. That effort is expected
to take years.
.
But the experts said that the
findings also meant that SARS, unlike some other new and emerging diseases, had
not weakened as it passed through successive generations. Some experts had
expressed hope that the virus would cause less severe illness as it spread.
.
Also, in a report on the outbreak in
Singapore, the U.S. Centers for Disease Control and Prevention said that five
individuals had acted as "superspreaders" in passing the virus to 144 other
people, while 81 percent of infected people did not transmit to anyone else.
.
The U.S. health agency defined
< < Back to Start of Article NEW YORK
The first major study of the genome of the SARS virus shows that it has not
mutated significantly in its spread to different countries.
.
The findings were encouraging because
if the virus remains stable, chances are increased that a vaccine might be
developed, the authors and other experts said Thursday. That effort is expected
to take years.
.
But the experts said that the
findings also meant that SARS, unlike some other new and emerging diseases, had
not weakened as it passed through successive generations. Some experts had
expressed hope that the virus would cause less severe illness as it spread.
.
Also, in a report on the outbreak in
Singapore, the U.S. Centers for Disease Control and Prevention said that five
individuals had acted as "superspreaders" in passing the virus to 144 other
people, while 81 percent of infected people did not transmit to anyone else.
.
The U.S. health agency defined
superspreaders as individuals who transmitted SARS to 10 or more people. Doctors
have described superspreaders in other infections like tuberculosis, rubella and
Ebola.
.
The director of the agency, Dr. Julie
Gerberding, said her agency was making available to state health departments the
biological material needed to perform a diagnostic blood test. The test detects
the antibodies that the immune system forms as it fights off infections; the
immune system produces a specific antibody against each microbe.
.
Researchers at the Centers for
Disease Control have developed a test like the Elisa, which is used to screen
for the AIDS virus and other infectious agents. The SARS test is expected to
have limited use because it cannot detect antibodies until three weeks after the
onset of illness. A positive result would strongly indicate that an individual
had been infected with the SARS virus, but a negative test would not necessarily
rule out such infection, Gerberding said.
.
"Probably the most important lesson
that we learned from the Singapore experience" is the need to "remain vigilant,"
she said. "If we were unfortunate to have someone with unrecognized SARS," who
could infect many others, "we could have a cascade of transmission."
.
The genome study, by Dr. Edison Liu
and his team in Singapore, involved comparing the complete genomes of SARS virus
from nine cases there with virus samples isolated in Canada, China, Hong Kong
and Vietnam. The study was published in The Lancet.
.
"This is the first major analysis of
this virus," said Dr. David Heymann, executive director of communicable diseases
at the World Health Organization. The Geneva-based agency has overall
responsibility for investigating the epidemic, which has affected 29 countries.
.
A number of laboratories have also
found that the SARS virus has not mutated significantly in the seven weeks since
it was detected, Heymann said.
.
Dr. Earl Brown, a virologist at the
University of Ottawa, said: "I hope that SARS will change, but I'm concerned.
This virus seems to be happy with the genes it's got." Brown, in a commentary on
the study in The Lancet, suggested that because the SARS virus had changed
relatively little in its first few months, it seemed unlikely to mutate into a
milder form.
.
In an interview, Brown said that if a
new virus was going to evolve into a more benign form, it normally did so in the
early months of an outbreak, a pattern followed by the Ebola virus, which causes
a deadly hemorrhagic fever.
.
"Ebola transmits like wildfire in
hospitals and among family members for two or three transmissions and then loses
the ability to infect people," he said. "It loses the ability to spread and keep
its virulence, and burns out on its own."
.
The World Health Organization has
said that a newly discovered member of the coronavirus family causes SARS. But
the agency and other scientists agree that more work needs to be done to be
certain.
.
The New York Times NEW YORK The first
major study of the genome of the SARS virus shows that it has not mutated
significantly in its spread to different countries.
.
The findings were encouraging because
if the virus remains stable, chances are increased that a vaccine might be
developed, the authors and other experts said Thursday. That effort is expected
to take years.
.
But the experts said that the
findings also meant that SARS, unlike some other new and emerging diseases, had
not weakened as it passed through successive generations. Some experts had
expressed hope that the virus would cause less severe illness as it spread.
.
Also, in a report on the outbreak in
Singapore, the U.S. Centers for Disease Control and Prevention said that five
individuals had acted as "superspreaders" in passing the virus to 144 other
people, while 81 percent of infected people did not transmit to anyone else.
.
The U.S. health agency defined
superspreaders as individuals who transmitted SARS to 10 or more people. Doctors
have described superspreaders in other infections like tuberculosis, rubella and
Ebola.
.
The director of the agency, Dr. Julie
Gerberding, said her agency was making available to state health departments the
biological material needed to perform a diagnostic blood test. The test detects
the antibodies that the immune system forms as it fights off infections; the
immune system produces a specific antibody against each microbe.
.
Researchers at the Centers for
Disease Control have developed a test like the Elisa, which is used to screen
for the AIDS virus and other infectious agents. The SARS test is expected to
have limited use because it cannot detect antibodies until three weeks after the
onset of illness. A positive result would strongly indicate that an individual
had been infected with the SARS virus, but a negative test would not necessarily
rule out such infection, Gerberding said.
.
"Probably the most important lesson
that we learned from the Singapore experience" is the need to "remain vigilant,"
she said. "If we were unfortunate to have someone with unrecognized SARS," who
could infect many others, "we could have a cascade of transmission."
.
The genome study, by Dr. Edison Liu
and his team in Singapore, involved comparing the complete genomes of SARS virus
from nine cases there with virus samples isolated in Canada, China, Hong Kong
and Vietnam. The study was published in The Lancet.
.
"This is the first major analysis of
this virus," said Dr. David Heymann, executive director of communicable diseases
at the World Health Organization. The Geneva-based agency has overall
responsibility for investigating the epidemic, which has affected 29 countries.
.
A number of laboratories have also
found that the SARS virus has not mutated significantly in the seven weeks since
it was detected, Heymann said.
.
Dr. Earl Brown, a virologist at the
University of Ottawa, said: "I hope that SARS will change, but I'm concerned.
This virus seems to be happy with the genes it's got." Brown, in a commentary on
the study in The Lancet, suggested that because the SARS virus had changed
relatively little in its first few months, it seemed unlikely to mutate into a
milder form.
.
In an interview, Brown said that if a
new virus was going to evolve into a more benign form, it normally did so in the
early months of an outbreak, a pattern followed by the Ebola virus, which causes
a deadly hemorrhagic fever.
.
"Ebola transmits like wildfire in
hospitals and among family members for two or three transmissions and then loses
the ability to infect people," he said. "It loses the ability to spread and keep
its virulence, and burns out on its own."
.
The World Health Organization has
said that a newly discovered member of the coronavirus family causes SARS. But
the agency and other scientists agree that more work needs to be done to be
certain.
.
The New York Times NEW YORK The first
major study of the genome of the SARS virus shows that it has not mutated
significantly in its spread to different countries.
.
The findings were encouraging because
if the virus remains stable, chances are increased that a vaccine might be
developed, the authors and other experts said Thursday. That effort is expected
to take years.
.
But the experts said that the
findings also meant that SARS, unlike some other new and emerging diseases, had
not weakened as it passed through successive generations. Some experts had
expressed hope that the virus would cause less severe illness as it spread.
.
Also, in a report on the outbreak in
Singapore, the U.S. Centers for Disease Control and Prevention said that five
individuals had acted as "superspreaders" in passing the virus to 144 other
people, while 81 percent of infected people did not transmit to anyone else.
.
The U.S. health agency defined
superspreaders as individuals who transmitted SARS to 10 or more people. Doctors
have described superspreaders in other infections like tuberculosis, rubella and
Ebola.
.
The director of the agency, Dr. Julie
Gerberding, said her agency was making available to state health departments the
biological material needed to perform a diagnostic blood test. The test detects
the antibodies that the immune system forms as it fights off infections; the
immune system produces a specific antibody against each microbe.
.
Researchers at the Centers for
Disease Control have developed a test like the Elisa, which is used to screen
for the AIDS virus and other infectious agents. The SARS test is expected to
have limited use because it cannot detect antibodies until three weeks after the
onset of illness. A positive result would strongly indicate that an individual
had been infected with the SARS virus, but a negative test would not necessarily
rule out such infection, Gerberding said.
.
"Probably the most important lesson
that
< < Back to Start of Article NEW YORK
The first major study of the genome of the SARS virus shows that it has not
mutated significantly in its spread to different countries.
.
The findings were encouraging because
if the virus remains stable, chances are increased that a vaccine might be
developed, the authors and other experts said Thursday. That effort is expected
to take years.
.
But the experts said that the
findings also meant that SARS, unlike some other new and emerging diseases, had
not weakened as it passed through successive generations. Some experts had
expressed hope that the virus would cause less severe illness as it spread.
.
Also, in a report on the outbreak in
Singapore, the U.S. Centers for Disease Control and Prevention said that five
individuals had acted as "superspreaders" in passing the virus to 144 other
people, while 81 percent of infected people did not transmit to anyone else.
.
The U.S. health agency defined
superspreaders as individuals who transmitted SARS to 10 or more people. Doctors
have described superspreaders in other infections like tuberculosis, rubella and
Ebola.
.
The director of the agency, Dr. Julie
Gerberding, said her agency was making available to state health departments the
biological material needed to perform a diagnostic blood test. The test detects
the antibodies that the immune system forms as it fights off infections; the
immune system produces a specific antibody against each microbe.
.
Researchers at the Centers for
Disease Control have developed a test like the Elisa, which is used to screen
for the AIDS virus and other infectious agents. The SARS test is expected to
have limited use because it cannot detect antibodies until three weeks after the
onset of illness. A positive result would strongly indicate that an individual
had been infected with the SARS virus, but a negative test would not necessarily
rule out such infection, Gerberding said.
.
"Probably the most important lesson
that we learned from the Singapore experience" is the need to "remain vigilant,"
she said. "If we were unfortunate to have someone with unrecognized SARS," who
could infect many others, "we could have a cascade of transmission."
.
The genome study, by Dr. Edison Liu
and his team in Singapore, involved comparing the complete genomes of SARS virus
from nine cases there with virus samples isolated in Canada, China, Hong Kong
and Vietnam. The study was published in The Lancet.
.
"This is the first major analysis of
this virus," said Dr. David Heymann, executive director of communicable diseases
at the World Health Organization. The Geneva-based agency has overall
responsibility for investigating the epidemic, which has affected 29 countries.
.
A number of laboratories have also
found that the SARS virus has not mutated significantly in the seven weeks since
it was detected, Heymann said.
.
Dr. Earl Brown, a virologist at the
University of Ottawa, said: "I hope that SARS will change, but I'm concerned.
This virus seems to be happy with the genes it's got." Brown, in a commentary on
the study in The Lancet, suggested that because the SARS virus had changed
relatively little in its first few months, it seemed unlikely to mutate into a
milder form.
.
In an interview, Brown said that if a
new virus was going to evolve into a more benign form, it normally did so in the
early months of an outbreak, a pattern followed by the Ebola virus, which causes
a deadly hemorrhagic fever.
.
"Ebola transmits like wildfire in
hospitals and among family members for two or three transmissions and then loses
the ability to infect people," he said. "It loses the ability to spread and keep
its virulence, and burns out on its own."
.
The World Health Organization has
said that a newly discovered member of the coronavirus family causes SARS. But
the agency and other scientists agree that more work needs to be done to be
certain.
.
The New York Times NEW YORK The first
major study of the genome of the SARS virus shows that it has not mutated
significantly in its spread to different countries.
.
The findings were encouraging because
if the virus remains stable, chances are increased that a vaccine might be
developed, the authors and other experts said Thursday. That effort is expected
to take years.
.
But the experts said that the
findings also meant that SARS, unlike some other new and emerging diseases, had
not weakened as it passed through successive generations. Some experts had
expressed hope that the virus would cause less severe illness as it spread.
.
Also, in a report on the outbreak in
Singapore, the U.S. Centers for Disease Control and Prevention said that five
individuals had acted as "superspreaders" in passing the virus to 144 other
people, while 81 percent of infected people did not transmit to anyone else.
.
The U.S. health agency defined
superspreaders as individuals who transmitted SARS to 10 or more people. Doctors
have described superspreaders in other infections like tuberculosis, rubella and
Ebola.
.
The director of the agency, Dr. Julie
Gerberding, said her agency was making available to state health departments the
biological material needed to perform a diagnostic blood test. The test detects
the antibodies that the immune system forms as it fights off infections; the
immune system produces a specific antibody against each microbe.
.
Researchers at the Centers for
Disease Control have developed a test like the Elisa, which is used to screen
for the AIDS virus and other infectious agents. The SARS test is expected to
have limited use because it cannot detect antibodies until three weeks after the
onset of illness. A positive result would strongly indicate that an individual
had been infected with the SARS virus, but a negative test would not necessarily
rule out such infection, Gerberding said.
.
"Probably the most important lesson
that we learned from the Singapore experience" is the need to "remain vigilant,"
she said. "If we were unfortunate to have someone with unrecognized SARS," who
could infect many others, "we could have a cascade of transmission."
.
The genome study, by Dr. Edison Liu
and his team in Singapore, involved comparing the complete genomes of SARS virus
from nine cases there with virus samples isolated in Canada, China, Hong Kong
and Vietnam. The study was published in The Lancet.
.
"This is the first major analysis of
this virus," said Dr. David Heymann, executive director of communicable diseases
at the World Health Organization. The Geneva-based agency has overall
responsibility for investigating the epidemic, which has affected 29 countries.
.
A number of laboratories have also
found that the SARS virus has not mutated significantly in the seven weeks since
it was detected, Heymann said.
.
Dr. Earl Brown, a virologist at the
University of Ottawa, said: "I hope that SARS will change, but I'm concerned.
This virus seems to be happy with the genes it's got." Brown, in a commentary on
the study in The Lancet, suggested that because the SARS virus had changed
relatively little in its first few months, it seemed unlikely to mutate into a
milder form.
.
In an interview, Brown said that if a
new virus was going to evolve into a more benign form, it normally did so in the
early months of an outbreak, a pattern followed by the Ebola virus, which causes
a deadly hemorrhagic fever.
.
"Ebola transmits like wildfire in
hospitals and among family members for two or three transmissions and then loses
the ability to infect people," he said. "It loses the ability to spread and keep
its virulence, and burns out on its own."
.
The World Health Organization has
said that a newly discovered member of the coronavirus family causes SARS. But
the agency and other scientists agree that more work needs to be done to be
certain.
.
The New York Times NEW YORK The first
major study of the genome of the SARS virus shows that it has not mutated
significantly in its spread to different countries.
.
The findings were encouraging because
if the virus remains stable, chances are increased that a vaccine might be
developed, the authors and other experts said Thursday. That effort is expected
to take years.
.
But the experts said that the
findings also meant that SARS, unlike some other new and emerging diseases, had
not weakened as it passed through successive generations. Some experts had
expressed hope that the virus would cause less severe illness as it spread.
.
Also, in a report on the outbreak in
Singapore, the U.S. Centers for Disease Control and Prevention said that five
individuals had acted as "superspreaders" in passing the virus to 144 other
people, while 81 percent of infected people did not transmit to anyone else.
.
The U.S. health agency defined
superspreaders as individuals who transmitted SARS to 10 or more people. Doctors
have described superspreaders in other infections like tuberculosis, rubella and
Ebola.
.
The director of the agency, Dr. Julie
Gerberding, said her agency was making available to state health departments the
biological material needed to perform a diagnostic blood test. The test detects
the antibodies that the immune system forms as it fights off infections; the
immune system produces a specific antibody against each microbe.
.
Researchers at the Centers for
Disease Control have developed a test like the Elisa, which is used to screen
for the AIDS virus and other infectious agents. The SARS test is expected to
have limited use because it cannot detect antibodies until three weeks after the
onset of illness. A positive result would strongly indicate that an individual
had been infected with the SARS virus, but a negative test would not necessarily
rule out such infection, Gerberding said.
.
"Probably the most important lesson
that we learned from the Singapore experience" is the need to "remain vigilant,"
she said. "If we were unfortunate to have someone with unrecognized SARS," who
could infect many others, "we could have a cascade of transmission."
.
The genome study, by Dr. Edison Liu
and his team in Singapore, involved comparing the complete genomes of SARS virus
from nine cases there with virus samples isolated in Canada, China, Hong Kong
and Vietnam. The study was published in The Lancet.
.
"This is the first major analysis of
this virus," said Dr. David Heymann, executive director of communicable diseases
at the World Health Organization. The Geneva-based agency has overall
responsibility for investigating the epidemic, which has affected 29 countries.
.
A number of laboratories have also
found that the SARS virus has not mutated significantly in the seven weeks since
it was detected, Heymann said.
.
Dr. Earl Brown, a virologist at the
University of Ottawa, said: "I hope that
< < Back to Start of Article NEW YORK
The first major study of the genome of the SARS virus shows that it has not
mutated significantly in its spread to different countries.
.
The findings were encouraging because
if the virus remains stable, chances are increased that a vaccine might be
developed, the authors and other experts said Thursday. That effort is expected
to take years.
.
But the experts said that the
findings also meant that SARS, unlike some other new and emerging diseases, had
not weakened as it passed through successive generations. Some experts had
expressed hope that the virus would cause less severe illness as it spread.
.
Also, in a report on the outbreak in
Singapore, the U.S. Centers for Disease Control and Prevention said that five
individuals had acted as "superspreaders" in passing the virus to 144 other
people, while 81 percent of infected people did not transmit to anyone else.
.
The U.S. health agency defined
superspreaders as individuals who transmitted SARS to 10 or more people. Doctors
have described superspreaders in other infections like tuberculosis, rubella and
Ebola.
.
The director of the agency, Dr. Julie
Gerberding, said her agency was making available to state health departments the
biological material needed to perform a diagnostic blood test. The test detects
the antibodies that the immune system forms as it fights off infections; the
immune system produces a specific antibody against each microbe.
.
Researchers at the Centers for
Disease Control have developed a test like the Elisa, which is used to screen
for the AIDS virus and other infectious agents. The SARS test is expected to
have limited use because it cannot detect antibodies until three weeks after the
onset of illness. A positive result would strongly indicate that an individual
had been infected with the SARS virus, but a negative test would not necessarily
rule out such infection, Gerberding said.
.
"Probably the most important lesson
that we learned from the Singapore experience" is the need to "remain vigilant,"
she said. "If we were unfortunate to have someone with unrecognized SARS," who
could infect many others, "we could have a cascade of transmission."
.
The genome study, by Dr. Edison Liu
and his team in Singapore, involved comparing the complete genomes of SARS virus
from nine cases there with virus samples isolated in Canada, China, Hong Kong
and Vietnam. The study was published in The Lancet.
.
"This is the first major analysis of
this virus," said Dr. David Heymann, executive director of communicable diseases
at the World Health Organization. The Geneva-based agency has overall
responsibility for investigating the epidemic, which has affected 29 countries.
.
A number of laboratories have also
found that the SARS virus has not mutated significantly in the seven weeks since
it was detected, Heymann said.
.
Dr. Earl Brown, a virologist at the
University of Ottawa, said: "I hope that SARS will change, but I'm concerned.
This virus seems to be happy with the genes it's got." Brown, in a commentary on
the study in The Lancet, suggested that because the SARS virus had changed
relatively little in its first few months, it seemed unlikely to mutate into a
milder form.
.
In an interview, Brown said that if a
new virus was going to evolve into a more benign form, it normally did so in the
early months of an outbreak, a pattern followed by the Ebola virus, which causes
a deadly hemorrhagic fever.
.
"Ebola transmits like wildfire in
hospitals and among family members for two or three transmissions and then loses
the ability to infect people," he said. "It loses the ability to spread and keep
its virulence, and burns out on its own."
.
The World Health Organization has
said that a newly discovered member of the coronavirus family causes SARS. But
the agency and other scientists agree that more work needs to be done to be
certain.
.
The New York Times NEW YORK The first
major study of the genome of the SARS virus shows that it has not mutated
significantly in its spread to different countries.
.
The findings were encouraging because
if the virus remains stable, chances are increased that a vaccine might be
developed, the authors and other experts said Thursday. That effort is expected
to take years.
.
But the experts said that the
findings also meant that SARS, unlike some other new and emerging diseases, had
not weakened as it passed through successive generations. Some experts had
expressed hope that the virus would cause less severe illness as it spread.
.
Also, in a report on the outbreak in
Singapore, the U.S. Centers for Disease Control and Prevention said that five
individuals had acted as "superspreaders" in passing the virus to 144 other
people, while 81 percent of infected people did not transmit to anyone else.
.
The U.S. health agency defined
superspreaders as individuals who transmitted SARS to 10 or more people. Doctors
have described superspreaders in other infections like tuberculosis, rubella and
Ebola.
.
The director of the agency, Dr. Julie
Gerberding, said her agency was making available to state health departments the
biological material needed to perform a diagnostic blood test. The test detects
the antibodies that the immune system forms as it fights off infections; the
immune system produces a specific antibody against each microbe.
.
Researchers at the Centers for
Disease Control have developed a test like the Elisa, which is used to screen
for the AIDS virus and other infectious agents. The SARS test is expected to
have limited use because it cannot detect antibodies until three weeks after the
onset of illness. A positive result would strongly indicate that an individual
had been infected with the SARS virus, but a negative test would not necessarily
rule out such infection, Gerberding said.
.
"Probably the most important lesson
that we learned from the Singapore experience" is the need to "remain vigilant,"
she said. "If we were unfortunate to have someone with unrecognized SARS," who
could infect many others, "we could have a cascade of transmission."
.
The genome study, by Dr. Edison Liu
and his team in Singapore, involved comparing the complete genomes of SARS virus
from nine cases there with virus samples isolated in Canada, China, Hong Kong
and Vietnam. The study was published in The Lancet.
.
"This is the first major analysis of
this virus," said Dr. David Heymann, executive director of communicable diseases
at the World Health Organization. The Geneva-based agency has overall
responsibility for investigating the epidemic, which has affected 29 countries.
.
A number of laboratories have also
found that the SARS virus has not mutated significantly in the seven weeks since
it was detected, Heymann said.
.
Dr. Earl Brown, a virologist at the
University of Ottawa, said: "I hope that SARS will change, but I'm concerned.
This virus seems to be happy with the genes it's got." Brown, in a commentary on
the study in The Lancet, suggested that because the SARS virus had changed
relatively little in its first few months, it seemed unlikely to mutate into a
milder form.
.
In an interview, Brown said that if a
new virus was going to evolve into a more benign form, it normally did so in the
early months of an outbreak, a pattern followed by the Ebola virus, which causes
a deadly hemorrhagic fever.
.
"Ebola transmits like wildfire in
hospitals and among family members for two or three transmissions and then loses
the ability to infect people," he said. "It loses the ability to spread and keep
its virulence, and burns out on its own."
.
The World Health Organization has
said that a newly discovered member of the coronavirus family causes SARS. But
the agency and other scientists agree that more work needs to be done to be
certain.
.
The New York Times NEW YORK The first
major study of the genome of the SARS virus shows that it has not mutated
significantly in its spread to different countries.
.
The findings were encouraging because
if the virus remains stable, chances are increased that a vaccine might be
developed, the authors and other experts said Thursday. That effort is expected
to take years.
.
But the experts said that the
findings also meant that SARS, unlike some other new and emerging diseases, had
not weakened as it passed through successive generations. Some experts had
expressed hope that the virus would cause less severe illness as it spread.
.
Also, in a report on the outbreak in
Singapore, the U.S. Centers for Disease Control and Prevention said that five
individuals had acted as "superspreaders" in passing the virus to 144 other
people, while 81 percent of infected people did not transmit to anyone else.
.
The U.S. health agency defined
superspreaders as individuals who transmitted SARS to 10 or more people. Doctors
have described superspreaders in other infections like tuberculosis, rubella and
Ebola.
.
The director of the agency, Dr. Julie
Gerberding, said her agency was making available to state health departments the
biological material needed to perform a diagnostic blood test. The test detects
the antibodies that the immune system forms as it fights off infections; the
immune system produces a specific antibody against each microbe.
.
Researchers at the Centers for
Disease Control have developed a test like the Elisa, which is used to screen
for the AIDS virus and other infectious agents. The SARS test is expected to
have limited use because it cannot detect antibodies until three weeks after the
onset of illness. A positive result would strongly indicate that an individual
had been infected with the SARS virus, but a negative test would not necessarily
rule out such infection, Gerberding said.
.
"Probably the most important lesson
that we learned from the Singapore experience" is the need to "remain vigilant,"
she said. "If we were unfortunate to have someone with unrecognized SARS," who
could infect many others, "we could have a cascade of transmission."
.
The genome study, by Dr. Edison Liu
and his team in Singapore, involved comparing the complete genomes of SARS virus
from nine cases there with virus samples isolated in Canada, China, Hong Kong
and Vietnam. The study was published in The Lancet.
.
"This is the first major analysis of
this virus," said Dr. David Heymann, executive director of communicable diseases
at the World Health Organization. The Geneva-based agency has overall
responsibility for investigating the epidemic, which has affected 29 countries.
.
A number of laboratories have also
found that the SARS virus has not mutated significantly in the seven weeks since
it was detected, Heymann said.
.
Dr. Earl Brown, a virologist at the
University of Ottawa, said: "I hope that SARS will change, but I'm concerned.
This virus seems to be happy with the genes it's got." Brown, in a commentary on
the study in The Lancet, suggested that because the SARS virus had changed
relatively little in its first few months, it seemed unlikely to mutate into a
milder form.
.
In an interview, Brown said that if a
new virus was going to evolve into a more benign form, it normally did so in the
early months of an outbreak, a pattern followed by the Ebola virus, which causes
a deadly hemorrhagic fever.
.
"Ebola transmits like wildfire in
hospitals and among family members for two or three transmissions and then loses
the ability to infect people," he said. "It loses the ability to spread and keep
its virulence, and burns out on its own."
.
The World Health Organization has
said that a newly discovered member of the coronavirus family causes SARS. But
the agency and other scientists agree that more work needs to be done to be
certain.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"